Bovista
LYCOPERDON UTRIFORME FRUITING BODY
ORAL
HUMAN OTC DRUG
Bovista is an FDA drug label for the active ingredient LYCOPERDON UTRIFORME FRUITING BODY manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231109.
- Generic name
- LYCOPERDON UTRIFORME FRUITING BODY
- Manufacturer
- Boiron
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 0220-0895
- Application
- N/A
- Label effective
- 20231109
Active ingredients
Bovista 6C (**contains 0.443 mg of the active ingredient per pellet)
Indications & Usage
Painful diarrhea with gas*
Dosage & Administration
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.